Cargando…
Frovatriptan 2.5 mg plus dexketoprofen (25 mg or 37.5 mg) in menstrually related migraine. Subanalysis from a double-blind, randomized trial
PURPOSE: The purpose of this article is to investigate the efficacy and safety of frovatriptan plus dexketoprofen 25 or 37.5 mg (FroDex25 or FroDex37.5, respectively) compared to that of frovatriptan 2.5 mg (Frova) in menstrually related migraine (MRM). AIM: The aim of this article is to analyze a s...
Autores principales: | Allais, G, Bussone, G, Tullo, V, Cortelli, P, Valguarnera, F, Barbanti, P, Sette, G, D’Onofrio, F, Curone, M, Benedetto, C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4261077/ https://www.ncbi.nlm.nih.gov/pubmed/25053749 http://dx.doi.org/10.1177/0333102414542290 |
Ejemplares similares
-
EHMTI-0052. Efficacy of early vs. late use of frovatriptan combined with dexketoprofen vs. frovatriptan alone in the acute treatment of migraine attacks with or without aura
por: Allais, G, et al.
Publicado: (2014) -
Efficacy of early vs. late use of frovatriptan combined with dexketoprofen vs. frovatriptan alone in the acute treatment of migraine attacks with or without aura
por: Allais, Gianni, et al.
Publicado: (2014) -
Frovatriptan plus dexketoprofen in the treatment of menstrually related migraine: an open study
por: Allais, Gianni, et al.
Publicado: (2013) -
Almotriptan 12.5 mg in menstrually related migraine: A
randomized, double-blind, placebo-controlled study
por: Allais, Gianni, et al.
Publicado: (2011) -
Randomized clinical trial of dexketoprofen/tramadol 25 mg/75 mg in moderate-to-severe pain after total hip arthroplasty
por: McQuay, H. J., et al.
Publicado: (2016)